A Multicentre Trial to Determine the Efficacy and Safety of Milnacipran in the Treatment of Fibromyalgia Syndrome

NCT00436033 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1429

Enrollment

INDUSTRY

Sponsor class

Conditions

Fibromyalgia Syndrome

Interventions

DRUG: milnacipran
DRUG: Placebo

Sponsor

Pierre Fabre Medicament